Lowbicar Tablets 10/40 mg
Amlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
MFDS item code 201404880 · Approved 2014.10.24
This product's status changed to Expired on 2024.10.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
Amlodipine or Olmesartan Medoxomil is a medication used for controlling blood pressure in patients with essential hypertension. Both medications help lower blood pressure and reduce the risk of cardiovascular complications. Amlodipine dilates blood vessels to lower blood pressure, while Olmesartan Medoxomil blocks the action of hormones that constrict blood vessels to regulate blood pressure. These medications can be used effectively to manage blood pressure when adequate control cannot be achieved through monotherapy. Thus, these medications are beneficial for the treatment of essential hypertension.
Take 1 tablet once daily with water, with or without food. It is recommended that you take it at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or olmesartan medoxomil). However, if blood pressure is not controlled with monotherapy using an individual component, switching directly to this medicine may be considered. The maximum dose of this medicine is 10/40 milligrams. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into account. The recommended doses are as follows: - 5/20 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams. - 10/20 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with olmesartan medoxomil 20 milligrams. - 5/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/40 milligrams. ∘Patients with renal impairment: This medicine has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil for patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 milligrams once daily. This medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients on dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with reduced intravascular volume: In patients who may have reduced intravascular volume (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while monitoring their condition closely. ∘Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil for patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. In patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics, blood pressure and renal function should be monitored closely. This medicine should not be administered to patients with severe hepatic impairment. (See section 2, Patients who should not take this medicine, under Precautions for Use.) ∘Older adults: Generally, start treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. In older adults, blood pressure should be monitored closely and more frequently.
The safety and efficacy have not been established in pediatric patients under 18 years of age.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, and it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the active ingredients or similar compounds, pregnant or breastfeeding women, those with severe liver impairment or certain heart conditions, patients undergoing renal dialysis, patients in a state of shock, and some diabetic patients should not take this medication. Patients with hypotension due to lack of fluids or salts, patients with sharp vasodilation, patients with severe heart disease, and those with poor kidney function should use this medication with caution and consult medical professionals immediately if symptoms of hypotension or other side effects occur. This medication may cause side effects such as dizziness, headache, hypotension, nausea, and edema, so patients should inform their doctor if these symptoms persist or worsen during treatment. During pregnancy, it can be especially dangerous to the fetus; therefore, those planning to become pregnant or currently pregnant should consult their physician, and breastfeeding women should consider stopping breastfeeding or discontinuing the medication. The safety and efficacy of this medication have not been established for patients under 18 years of age. Elderly patients should have their dosage adjusted considering renal and liver function and be cautious of side effects. Overdose may result in hypotension and heart problems, so patients must adhere to the prescribed dosage, and seek emergency treatment immediately if abnormal symptoms occur. This medication should be stored in a tightly closed container away from moisture, heat, and direct sunlight, and it is advisable not to transfer it to another container. Additionally, interactions may occur when taking other medications, so patients should inform their healthcare provider if they are on any other medications.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best kept at room temperature between 1°C and 30°C. It is important to avoid very hot or very cold places to maintain the medication's effectiveness.
Brownish-red round film-coated tablet
30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
CombinationAmlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
CombinationAmlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Korea Hyuntex Pharmaceutical Co., Ltd.
Amlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Ilseong IS Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Korea United Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.